-
Event
20 November 2026, The Hotel Brussels & Online
Advancing Collaboration, Skills and Person-Centred Care through INTERACT-EUROPE 100
Bringing together Europe’s oncology community at a pivotal moment, this conference will showcase the achievements of INTERACT-EUROPE 100 while charting the next phase of inter-speciality cancer training across Europe. It offers a unique opportunity to transform the programme’s success into lasting, system-wide adoption, ultimately advancing cancer care and outcomes for people across Europe.
Read more
-
Event
20 November 2026, The Hotel Brussels
Quality of life is a key priority for anyone affected by cancer, but it remains insufficiently addressed in cancer research, care and policy.
On 20 November, the Quality of Life and Cancer Policy Forum will explore lessons from nine innovative projects and how cancer systems can be redesigned towards patient-centred care.
Taking place a day after the European Cancer Summit 2026 – and at the same venue – this high-level, implementation-focused event will bring together patient representatives, researchers, healthcare professionals, health system managers and policymakers to learn about the latest EU-supported initiatives and get empowered to drive meaningful change.
This event will feature:
- the EUonQoL project, developing a patient-centred unified tool for the assessment of quality of life among cancer patients and survivors – serving as its final policy event
- the projects of the Quality of Life - Patient-Centred Care Cluster of the EU Mission on Cancer – serving as their multi-stakeholder meeting
Read more
-
Event
18 - 19 November 2026, Brussels & online
Strengthening Cancer Care: Securing a Healthy, Equitable, Resilient and Competitive Europe
Amid political instability, economic pressure, and the risk of escalating conflict, discussions around Europe’s next multiannual budget are intensifying in Brussels and in capitals across the EU.
In this environment, addressing the growing burden of cancer is essential. This unrelenting disease is not only a public health priority, but a strategic investment in Europe’s resilience, social cohesion and long‑term competitiveness.
As Europe defines its political priorities for the decade ahead, health and cancer must be embedded at the heart of future investments. At this critical moment, the cancer community must champion a vision for a resilient, equitable and innovative Europe.
The European Cancer Summit 2026 will take place in Brussels & online on 18-19 November, followed by EU-funded project events on 20 November.
Read more
-
Event
13 July 2026, Online
Patient-Reported Outcome Measures (PROMs) are essential tools for ensuring that cancer care, research and health decision-making reflect the experiences and priorities of patients.
By systematically collecting information directly from patients, PROMs can help improve clinical communication, identify symptoms and complications earlier, support better treatment decisions and strengthen the evidence base for patient-centred cancer care.
For this reason, on 13 July we will host a Community 365 Roundtable dedicated to PROMs. Co-chaired by Monica Racovita and Nicolò Battisti, the roundtable will bring together policymakers, clinicians, patient advocates, researchers and healthcare innovators to examine how Europe can move from fragmented implementation towards more systematic use of PROMs in cancer care.
Read more
-
Publication
June 2026
The European Cancer Organisation has published a new policy action report, titled ‘Delivering Precision Cancer Medicine at Scale’, calling for stronger European action to ensure that advances in precision cancer medicine are translated into equitable patient access.
Read more
-
Publication
June 2026
Health literacy is increasingly recognised as a crucial element in the evolving healthcare landscape. As healthcare systems shift towards digital platforms, it is imperative that individuals are equipped with the skills necessary to assess, comprehend, and effectively utilise health information in all its forms.
Read more
-
news
03 June 2026
Joint letter to the European Commission, EU Council and Member States warns that a competitive economy requires a healthy population
Every year, Europe loses a staggering €442 billion in productivity because of avoidable deaths linked to non-communicable diseases alone, according to the World Health Organization1.
Yet, as negotiations intensify over the European Union’s next Multiannual Financial Framework (MFF), health risks slipping down the political agenda at precisely the moment Europe is placing competitiveness, resilience and economic security at the centre of its future strategy.
Read more
-
news
26 May 2026
Each year in Europe, 2 million lives are lost due to cancer. Many of them could have been saved through early detection.
Early detection can raise survival rates by up to 13 times for some common cancers, while late detection can lead to less than 10% survival after five years.
This European Week Against Cancer, on the day dedicated to early detection of cancer, the European Cancer Organisation unveils the new 2026 European Cancer Screening Policy Index, calling attention to the urgent need for stronger and more equitable cancer screening policies across the continent.
Read more
-
Publication
May 2026
Every year, 2 million lives are lost due to cancer, many of them because the disease was detected too late. Early detection can raise survival rates by up to 13 times for some common cancers, while late detection can lead to less than 10% survival after five years.
Evidence-based cancer screening implementation remains one of the most effective ways to improve cancer outcomes, yet major disparities in policies and participation persist across Europe.
Read more
